ALDOMET
ALDOMET: Overview and Nomenclature The compound marketed under the brand name ALDOMET constitutes one of the foundational agents in the pharmacological management of hypertension, identifying chemically as methyldopa. Methyldopa, or alpha-methyldopa, is formally classified as a centrally acting adrenergic inhibitor, a class of medication specifically designed to reduce blood pressure by affecting the central nervous […]